Advances in patented CB1 receptor antagonists for obesity

Pharm Pat Anal. 2018 Sep;7(5):169-173. doi: 10.4155/ppa-2018-0020. Epub 2018 Aug 1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cannabinoid Receptor Antagonists / therapeutic use*
  • Humans
  • Molecular Targeted Therapy / methods
  • Obesity / drug therapy*
  • Patents as Topic

Substances

  • Cannabinoid Receptor Antagonists